Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

China grants approval to GSK’s Benlysta for lupus nephritis treatment

Pharmaceutical-TechnologyFebruary 14, 2022

Tag: Benlysta , belimumab , LN

PharmaSources Customer Service